• Intellia Therapeutics Shares Plunge on Clinical Trial Safety Concerns AD HOC NEWS Mon, 17 Nov 2025 13:05:05 GMT
• 1 Underrated Stock That Could Soar by 58%, According to Wall Street AOL.com Mon, 17 Nov 2025 12:22:54 GMT
• intellia therapeutics faces severe setback following clinical trial death AD HOC NEWS Mon, 17 Nov 2025 04:02:05 GMT
• can volume confirm reversal in intellia therapeutics inc. - 2025 market wrapup & stepwise trade signal guides newser.com Sun, 16 Nov 2025 22:11:51 GMT
• will intellia therapeutics inc. (38i) stock benefit from mergers - 2025 key lessons & ai based buy/sell signal reports newser.com Sun, 16 Nov 2025 21:27:38 GMT
• will intellia therapeutics inc. (38i) stock outperform value peers - trade performance summary & risk controlled swing alerts newser.com Sun, 16 Nov 2025 20:21:35 GMT
• StockWatch: Korro Craters 81% on Data; Patient Death Sours Analysts on Intellia Genetic Engineering and Biotechnology News Sun, 16 Nov 2025 19:09:31 GMT
• can technical indicators confirm intellia therapeutics inc.’s reversal newser.com Sun, 16 Nov 2025 18:32:40 GMT
• Analysts’ Opinions Are Mixed on These Healthcare Stocks: Intellia Therapeutics (NTLA) and Acrivon Therapeutics, Inc. (ACRV) The Globe and Mail Sun, 16 Nov 2025 16:57:34 GMT
• why intellia therapeutics inc. (38i) stock remains top rated - july 2025 breakouts & safe entry point identification newser.com Sun, 16 Nov 2025 12:19:09 GMT
• Is Intellia Therapeutics Inc. (38I) stock a buy on weakness - July 2025 Levels & Technical Entry and Exit Tips newser.com Sun, 16 Nov 2025 11:58:50 GMT
• clinical trial setback sends intellia therapeutics shares into decline AD HOC NEWS Sun, 16 Nov 2025 04:55:04 GMT
• How Intellia Therapeutics Inc. stock reacts to oil prices - 2025 Market Trends & Fast Entry Momentum Trade Alerts newser.com Sun, 16 Nov 2025 02:29:46 GMT
• how intellia therapeutics inc. stock performs in weak economy - july 2025 endofmonth & real-time volume triggers newser.com Sun, 16 Nov 2025 00:52:41 GMT
• how intellia therapeutics inc. stock performs in weak economy - cpi data & reliable breakout forecasts newser.com Sat, 15 Nov 2025 23:59:34 GMT
• why intellia therapeutics inc. (38i) stock remains top rated - 2025 trading recap & high accuracy trade signal alerts newser.com Sat, 15 Nov 2025 22:32:44 GMT
• what to expect from intellia therapeutics inc. in the next 30 days - 2025 big picture & real-time volume surge alerts newser.com Sat, 15 Nov 2025 22:01:26 GMT
• algonquin, spotify, keysight, intellia, coreweave: trending by analysts TipRanks Sat, 15 Nov 2025 09:02:26 GMT
• will intellia therapeutics inc. (38i) stock outperform value peers - 2025 analyst calls & weekly top gainers alerts newser.com Sat, 15 Nov 2025 07:38:19 GMT
• will intellia therapeutics inc. (38i) stock recover faster than industry - 2025 breakouts & breakdowns & free expert verified stoc... newser.com Sat, 15 Nov 2025 01:56:50 GMT
• will intellia therapeutics inc. (38i) stock recover faster than industry - july 2025 market mood & low drawdown investment strateg... newser.com Fri, 14 Nov 2025 19:51:39 GMT
• what data driven models say about intellia therapeutics inc.’s future - earnings recap report & verified chart pattern signals newser.com Fri, 14 Nov 2025 17:34:51 GMT
• Can NTLA Stock Bounce Back in 2026 After Recent Pipeline Setbacks? Zacks Investment Research Fri, 14 Nov 2025 13:32:21 GMT
• will intellia therapeutics inc. (38i) stock benefit from mergers - 2025 performance recap & real-time buy signal notifications newser.com Fri, 14 Nov 2025 05:55:40 GMT
• will intellia therapeutics inc. (38i) stock outperform value peers - july 2025 market mood & target return focused picks newser.com Fri, 14 Nov 2025 05:13:28 GMT
• why intellia therapeutics inc. (38i) stock remains top rated - 2025 retail activity & real-time price movement reports newser.com Fri, 14 Nov 2025 03:31:50 GMT
• can volume confirm reversal in intellia therapeutics inc. - july 2025 short interest & accurate buy signal alerts newser.com Fri, 14 Nov 2025 00:01:09 GMT
• why intellia therapeutics inc. (38i) stock remains top rated - market activity report & safe entry momentum tips newser.com Thu, 13 Nov 2025 23:12:18 GMT
• can intellia therapeutics inc. stock deliver strong q4 earnings - july 2025 fed impact & scalable portfolio growth methods newser.com Thu, 13 Nov 2025 21:43:51 GMT
• Korro to cut staff, shift strategy as RNA editing drug misses mark in early testing BioPharma Dive Thu, 13 Nov 2025 16:27:27 GMT
• will intellia therapeutics inc. (38i) stock benefit from mergers - 2025 technical overview & stepwise swing trade plans newser.com Thu, 13 Nov 2025 12:16:06 GMT
• can technical indicators confirm intellia therapeutics inc.’s reversal - july 2025 momentum & low risk high reward trade ideas newser.com Thu, 13 Nov 2025 10:09:59 GMT
• intellia therapeutics stock hits day low of $8.96 amid price pressure Markets Mojo Thu, 13 Nov 2025 05:11:05 GMT
• can intellia therapeutics inc. stock deliver strong q4 earnings - market activity report & long-term safe investment plans newser.com Wed, 12 Nov 2025 22:36:25 GMT
• FDA unveils new regulatory roadmap for bespoke drug therapies BioPharma Dive Wed, 12 Nov 2025 22:03:57 GMT
• will intellia therapeutics inc. (38i) stock recover faster than industry - 2025 top gainers & trade opportunity analysis newser.com Wed, 12 Nov 2025 21:27:11 GMT
• What Does a 58% Drop Mean for Intellia Therapeutics Stock in 2025? simplywall.st Wed, 12 Nov 2025 20:55:04 GMT
• can technical indicators confirm intellia therapeutics inc.’s reversal - 2025 volatility report & reliable trade execution plans newser.com Wed, 12 Nov 2025 16:44:17 GMT
• Intellia Therapeutics (NTLA) Downgraded Amid Safety Concerns GuruFocus Wed, 12 Nov 2025 15:06:22 GMT
• intellia cut to peer perform at wolfe research on nex-z safety issues Seeking Alpha Wed, 12 Nov 2025 14:35:58 GMT
• JonesTrading downgrades Intellia Therapeutics (NTLA) to a Hold The Globe and Mail Wed, 12 Nov 2025 12:54:04 GMT
• ntla sees another downgrade as wolfe research adjusts rating | n GuruFocus Wed, 12 Nov 2025 12:43:51 GMT
• can volume confirm reversal in intellia therapeutics inc. - 2025 technical patterns & long-term growth portfolio plans newser.com Wed, 12 Nov 2025 12:36:48 GMT
• Intellia Therapeutics (NTLA) Downgraded by Wolfe Research Due to Safety Concerns GuruFocus Wed, 12 Nov 2025 10:39:44 GMT
• intellia therapeutics (ntla) was downgraded to a hold rating at evercore isi The Globe and Mail Wed, 12 Nov 2025 09:47:53 GMT
• is intellia therapeutics inc. (38i) stock trading at attractive multiples - 2025 historical comparison & risk adjusted buy and sel... newser.com Wed, 12 Nov 2025 08:55:52 GMT
• evercore isi downgrades intellia therapeutics stock rating to in line by investing.com Investing.com South Africa Wed, 12 Nov 2025 06:46:32 GMT
• intellia therapeutics shares plunge on clinical trial setbacks AD HOC NEWS Wed, 12 Nov 2025 06:11:04 GMT
• analysts offer insights on healthcare companies: intellia therapeutics (ntla), tandem diabetes care (tndm) and palvella therapeuti... The Globe and Mail Wed, 12 Nov 2025 02:35:26 GMT
• wolfe research downgrades intellia therapeutics(ntla.us) to hold rating 富途牛牛 Tue, 11 Nov 2025 23:31:00 GMT
• is a relief rally coming for intellia therapeutics inc. holders - 2025 bull vs bear & ai forecasted stock moves newser.com Tue, 11 Nov 2025 21:25:11 GMT
• Intellia Therapeutics (NTLA) Downgraded to 'Hold' by Jones Tradi GuruFocus Tue, 11 Nov 2025 20:32:47 GMT
• Intellia Therapeutics (NTLA): Assessing Valuation After FDA Clinical Hold on Lead Gene-Editing Program Yahoo Finance Tue, 11 Nov 2025 19:23:26 GMT
• will intellia therapeutics inc. (38i) stock outperform value peers - weekly profit recap & reliable volume spike alerts newser.com Tue, 11 Nov 2025 18:36:50 GMT
• intellia therapeutics faces critical juncture following patient death AD HOC NEWS Tue, 11 Nov 2025 14:22:05 GMT
• Intellia Therapeutics stock downgraded to Hold by Jones Trading after patient death Investing.com Tue, 11 Nov 2025 13:55:32 GMT
• jones downgrades intellia therapeutics to neutral from buy MarketScreener Tue, 11 Nov 2025 13:40:17 GMT
• intellia therapeutics downgraded to hold from buy at jonesresearch TipRanks Tue, 11 Nov 2025 13:13:16 GMT
• evercore isi downgrades intellia therapeutics to in line from outperform, adjusts pt to $8 from $17 MarketScreener Tue, 11 Nov 2025 12:22:20 GMT
• this sps commerce analyst is no longer bullish; here are top 3 downgrades for tuesday Benzinga Tue, 11 Nov 2025 12:05:53 GMT
• What 21 Analyst Ratings Have To Say About Intellia Therapeutics Benzinga Tue, 11 Nov 2025 11:45:05 GMT
• how sentiment analysis helps forecast intellia therapeutics inc. - quarterly market review & daily profit maximizing trade tips newser.com Tue, 11 Nov 2025 11:14:06 GMT
• evercore isi group downgrades ntla with significant price target cut | ntla stock news GuruFocus Tue, 11 Nov 2025 10:37:29 GMT
• Intellia Therapeutics downgraded to In Line from Outperform at Evercore ISI TipRanks Tue, 11 Nov 2025 10:20:50 GMT
• crispr's mixed week: breakthrough heart health treatment and a patient death BioXconomy Tue, 11 Nov 2025 10:17:09 GMT
• evercore isi downgrades intellia therapeutics stock rating to in line Investing.com India Tue, 11 Nov 2025 09:36:26 GMT
• intellia therapeutics stock hits day low of $8.96 amid price pressure Markets Mojo Tue, 11 Nov 2025 09:07:46 GMT
• intellia therapeutics faces critical regulatory hurdle despite promising trial data AD HOC NEWS Tue, 11 Nov 2025 05:14:03 GMT
• HC Wainwright & Co. Maintains Intellia Therapeutics (NTLA) Buy Recommendation Nasdaq Tue, 11 Nov 2025 00:11:00 GMT
• crispr therapeutics' gene-editing drug cuts ldl cholesterol, triglycerides in early human trial Precision Medicine Online Mon, 10 Nov 2025 23:30:34 GMT
• Intellia Therapeutics Presents Positive Clinical Data for Lonvoguran and Nexiguran TradingView Mon, 10 Nov 2025 22:35:00 GMT
• Why These Two Gene-Editing Stocks Just Diverged Investor's Business Daily Mon, 10 Nov 2025 21:58:00 GMT
• Reporter’s Notebook: Is Intellia’s Patient Death the Nail in the Coffin for Cas9? Inside Precision Medicine Mon, 10 Nov 2025 21:10:35 GMT
• intellia reports durable ttr reduction in attr amyloidosis treatment by investing.com Investing.com South Africa Mon, 10 Nov 2025 21:09:23 GMT
• intellia therapeutics (ntla) reports positive outcomes in phase 1 study GuruFocus Mon, 10 Nov 2025 21:00:56 GMT
• intellia announces ‘positive’ follow-up data from ongoing phase 1 nex-z trial TipRanks Mon, 10 Nov 2025 20:45:21 GMT
• Intellia Therapeutics Presents Positive Longer-Term Phase 1 Data of Nexiguran Ziclumeran (nex-z) in Patients with Transthyretin (A... Intellia Therapeutics Mon, 10 Nov 2025 20:18:12 GMT
• Intellia (NASDAQ: NTLA) reports 81% NYHA stability at 24 months in nex-z Phase 1 Stock Titan Mon, 10 Nov 2025 20:17:00 GMT
• Intellia Therapeutics, Inc. Securities Lawsuit Investigation Claim Depot Mon, 10 Nov 2025 20:09:48 GMT
• gene-editing therapy trials on hold after elderly man's death FAP News Today Mon, 10 Nov 2025 18:01:31 GMT
• ntla: truist securities reiterates buy rating but lowers price t GuruFocus Mon, 10 Nov 2025 17:43:36 GMT
• intellia therapeutics price target lowered to $14 from $25 at truist TipRanks Mon, 10 Nov 2025 15:47:53 GMT
• can intellia therapeutics inc. stock deliver strong q4 earnings - dip buying & smart allocation stock reports newser.com Mon, 10 Nov 2025 15:05:29 GMT
• Intellia Therapeutics stock soars on positive HAE treatment data Investing.com Mon, 10 Nov 2025 14:16:33 GMT
• truist cuts price target on intellia therapeutics to $14 from $25, keeps buy rating MarketScreener Mon, 10 Nov 2025 13:48:23 GMT
• intellia therapeutics price target lowered to $15 from $18 at h.c. wainwright TipRanks Mon, 10 Nov 2025 13:30:34 GMT
• hc wainwright maintains buy rating on ntla, lowers price target | ntla stock news GuruFocus Mon, 10 Nov 2025 13:05:04 GMT
• is intellia therapeutics inc. (38i) stock a buy on weakness - july 2025 selloffs & expert-curated trade recommendations newser.com Mon, 10 Nov 2025 09:06:17 GMT
• five things for pharma marketers to know for monday, november 10, 2025 Medical Marketing and Media Mon, 10 Nov 2025 09:04:06 GMT
• Intellia Therapeutics (NTLA): Assessing Valuation After Recent Share Price Decline simplywall.st Mon, 10 Nov 2025 08:31:34 GMT
• can a trend reversal in intellia therapeutics inc. lead to recovery - quarterly investment review & real-time buy zone alerts newser.com Mon, 10 Nov 2025 07:46:01 GMT
• intellia therapeutics (ntla) shares promising hereditary angioed GuruFocus Sun, 09 Nov 2025 18:57:37 GMT
• chart overlay techniques for tracking intellia therapeutics inc. - watch list & real-time volume trigger notifications newser.com Sun, 09 Nov 2025 13:59:17 GMT
• intellia therapeutics price target lowered to $9 from $14 at rbc capital MSN Sun, 09 Nov 2025 11:31:35 GMT
• intellia therapeutics, inc. (nasdaq:ntla) q3 2025 earnings call transcript Insider Monkey Sun, 09 Nov 2025 06:32:28 GMT
• Patient Treated in Trial for Intellia’s Transthyretin Amyloidosis Gene Editing Therapy Nex-Z Dies CGTLive® Sun, 09 Nov 2025 02:34:20 GMT
• Why Intellia Therapeutics (NTLA) Lonvo-z Data Spotlight Raises New Questions About Long-Term Competitive Advantage simplywall.st Sun, 09 Nov 2025 01:48:20 GMT
• Intellia Therapeutics Presents Positive Pooled Phase 1/2 GlobeNewswire Sat, 08 Nov 2025 22:13:00 GMT
• intellia therapeutics’ stock rocked by patient death in gene therapy trial MSN Sat, 08 Nov 2025 17:29:08 GMT
• intellia therapeutics faces woes as price targets slashed amid safety concerns StocksToTrade Sat, 08 Nov 2025 13:50:00 GMT
• Chardan Capital Maintains Intellia Therapeutics (NTLA) Buy Recommendation Nasdaq Sat, 08 Nov 2025 08:00:00 GMT
• Intellia Therapeutics (NASDAQ: NTLA) reports 89% kallikrein reduction at 24 months in HAE Stock Titan Sat, 08 Nov 2025 08:00:00 GMT
• intellia therapeutics’ earnings call: progress amid challenges TipRanks Sat, 08 Nov 2025 00:56:44 GMT
• Wedbush Maintains Intellia Therapeutics (NTLA) Neutral Recommendation Nasdaq Sat, 08 Nov 2025 00:04:00 GMT
• ntla: analyst chardan capital lowers price target; maintains buy rating | ntla stock news GuruFocus Fri, 07 Nov 2025 23:40:19 GMT
• how intellia therapeutics inc. (ntla) affects rotational strategy timing news.stocktradersdaily.com Fri, 07 Nov 2025 22:18:04 GMT
• gene-editing stock crashes after patient in pivotal study dies Investor's Business Daily Fri, 07 Nov 2025 21:11:00 GMT
• wells fargo lowers pt on intellia therapeutics (ntla), maintains rating | ntla stock news GuruFocus Fri, 07 Nov 2025 20:11:22 GMT
• ntla: rbc capital maintains rating, lowers price target by 36% | GuruFocus Fri, 07 Nov 2025 19:53:12 GMT
• Intellia Therapeutics patient death prompts FDA clinical hold on CRISPR heart disease trials The Business Journals Fri, 07 Nov 2025 17:23:00 GMT
• rbc adjusts price target on intellia therapeutics to $9 from $14, maintains sector perform rating MarketScreener Fri, 07 Nov 2025 16:37:21 GMT
• jp morgan downgrades intellia therapeutics (ntla) with lower pri GuruFocus Fri, 07 Nov 2025 16:30:29 GMT
• patient dies in intellia trial; fda awards 6 more ‘national priority’ vouchers BioPharma Dive Fri, 07 Nov 2025 16:09:31 GMT
• intellia therapeutics price target lowered to $9 from $14 at rbc capital TipRanks Fri, 07 Nov 2025 16:02:29 GMT
• intellia therapeutics reports q3 eps (92c) vs. ($1.34) last year TipRanks Fri, 07 Nov 2025 16:00:32 GMT
• wedbush maintains ntla rating, lowers price target to $7 | ntla stock news GuruFocus Fri, 07 Nov 2025 15:41:40 GMT
• intellia q3 loss narrower than expected, stock down on pipeline trouble Yahoo Finance Fri, 07 Nov 2025 14:56:00 GMT
• ntla's analyst rating maintained but price target lowered | ntla stock news GuruFocus Fri, 07 Nov 2025 14:44:25 GMT
• oppenheimer maintains intellia therapeutics(ntla.us) with buy rating, cuts target price to $27 富途牛牛 Fri, 07 Nov 2025 14:31:00 GMT
• intellia therapeutics (ntla) reports strong revenue growth and s GuruFocus Fri, 07 Nov 2025 14:28:14 GMT
• j.p. morgan downgrades intellia therapeutics(ntla.us) to sell rating, announces target price $5 富途牛牛 Fri, 07 Nov 2025 14:28:00 GMT
• intellia therapeutics price target lowered to $27 from $33 at oppenheimer TipRanks Fri, 07 Nov 2025 14:07:24 GMT
• 2 small-cap stocks with far more upside than any "magnificent seven" stock, according to wall street The Motley Fool Fri, 07 Nov 2025 13:45:00 GMT
• intellia shares fall after hospitalised crispr patient dies pharmaphorum Fri, 07 Nov 2025 13:38:14 GMT
• intellia therapeutics (ntla) shares plunge after phase 3 trial s GuruFocus Fri, 07 Nov 2025 13:15:56 GMT
• a quick look at today's ratings for intellia therapeutics(ntla.us), with a forecast between $14 to $26 富途牛牛 Fri, 07 Nov 2025 13:00:01 GMT
• jpmorgan downgrades intellia therapeutics to underweight from neutral, adjusts price target to $5 from $12 MarketScreener Fri, 07 Nov 2025 12:56:01 GMT
• intellia therapeutics: hold rating amid safety concerns and regulatory challenges TipRanks Fri, 07 Nov 2025 12:49:38 GMT
• intellia therapeutics price target lowered to $4 from $9 at baird TipRanks Fri, 07 Nov 2025 12:46:45 GMT
• intellia therapeutics price target lowered to $21 from $29 at citizens jmp TipRanks Fri, 07 Nov 2025 12:45:18 GMT
• intellia therapeutics price target lowered to $14 from $24 at barclays TipRanks Fri, 07 Nov 2025 11:57:19 GMT
• intellia therapeutics price target lowered to $12 from $17 at wells fargo TipRanks Fri, 07 Nov 2025 11:50:58 GMT
• Patient hospitalised after receiving Intellia's CRISPR therapy dies FirstWord Pharma Fri, 07 Nov 2025 11:28:02 GMT
• intellia therapeutics (ntla) faces setback with fda hold on key trials GuruFocus Fri, 07 Nov 2025 11:03:39 GMT
• intellia therapeutics stock rating maintained at neutral by baird Investing.com Fri, 07 Nov 2025 10:58:11 GMT
• cautious hold rating on intellia therapeutics amid safety concerns and regulatory uncertainty TipRanks Fri, 07 Nov 2025 10:42:44 GMT
• intellia therapeutics downgraded to underweight from neutral at jpmorgan TipRanks Fri, 07 Nov 2025 10:41:15 GMT
• transcript : intellia therapeutics, inc., q3 2025 earnings call, nov 06, 2025 MarketScreener Fri, 07 Nov 2025 10:36:35 GMT
• jpmorgan downgrades intellia therapeutics stock on liver toxicity concerns Investing.com Fri, 07 Nov 2025 09:46:36 GMT
Intellia Therapeutics, Inc(NASDAQ:NTLA) 
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. It utilizes a biological tool known as the Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. The company's in vivo programs include NTLA-2001, which i...
Website: http://www.intelliatx.com
Founded: 2014
Full Time Employees: 270
CEO: John Leonard
Sector: Healthcare
Industry: Biotechnology